CDXC Stock | News | Quote | Stock Forum | Sunday, October 6,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
ChromaDex Inc. CDXC Company Overview 

Stock Message Board http://investorshangout.com/search?q=CDXC&...mp;yt1=Go!

Last Updated: Sunday, October 6, 2013 8:44:13 PM

ChromaDex Inc. CDXC Current Price and Quotes
Last Price 0.80
Previous Close 0.80 Open 0.80
Daily Range 0.82 - 0.795 52wk Range 0.979 - 0.50
Volume 239,230 Dividend N/A
Average Vol (3m) 163,760 Yield N/A
ChromaDex Inc. CDXC

Company Verified Profile
Company Information

10005 Muirlands Boulevard
Suite G
Irvine, CA 92618

Website: http://www.chromadex.com
Phone: 949-419-0288
Email: jamesl@chromadex.com

ChromaDex Inc. CDXC
ChromaDex, Inc. is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries. ChromaDex's pipeline of proprietary products include patented pTeroPure pterostilbene, which was named the 2010 North American Most Promising Ingredient of the Year by the independent research company Frost & Sullivan. The company has also launched ProC3G, a natural black ri...



ChromaDex Inc. CDXC
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 29, 2013 10-Q
CIK 0001386570
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2833 - Medicinal and botanicals
Business Status Development Stage Company a/o Dec 17, 2012
Incorporated In: DE, USA
Year of Inc. 1999
Employees 73 a/o Dec 17, 2012
Company Officers/Contacts

Frank L. Jaksch CEO, President
Thomas C. Varvaro CFO
James Lee Controller
Laura Carney Executive Assistant, IR
Company Directors

Michael Brauser
Barry Honig
Curtis A. Lockshin
Company Notes

Formerly=Cody Resources, Inc. until 7-2008
Service Providers

Auditor/Accountant
McGladrey & Pullen, LLP
One Valley Square, Suite 250
512 Township Line Rd.
Blue Bell, PA, 19422-2700
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
Not Available

ChromaDex Inc. CDXC
CDXC Security Details

Share Structure

Market Value1 $81,045,731 a/o Oct 04, 2013
Shares Outstanding 101,307,164 a/o Aug 12, 2013
Float 56,109,651 a/o Dec 17, 2012
Authorized Shares 150,000,000 a/o Dec 17, 2012
Par Value  0.001
Shareholders

Shareholders of Record 86 a/o Mar 29, 2013
Security Notes

Capital Change=shs increased by 11.538461 for 1 split. Ex-date=03/28/2008. Rec date=03/28/2008. Pay date=03/28/2008.
Short Selling Data

Short Interest 164,129 (-0.14%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Island Stock Transfer

ChromaDex Inc. CDXC Financials
Period Ending Dec 29, 2012 Dec 31, 2011 Jan 01, 2011 Jan 02, 2010
Total Revenue 11,610 8,113 7,566 5,778
Cost of Revenue 9,335 5,641 4,622 3,736
Gross Profit 2,275 2,472 2,945 2,041
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 13,912 10,336 4,962 2,934
Non-Recurring Items - - - -
Other - - - -
Operating Income (11,636) (7,864) (2,017) (893)
Income From Continuing Operations

Add'l Income/Expense Items 3 1 2 2
Earnings Before Interest and Tax (11,633) (7,863) (2,016) (890)
Interest Expense 29 32 36 17
Earnings Before Tax (11,662) (7,895) (2,052) (908)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,662) (7,895) (2,052) (908)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,662) (7,895) (2,052) (908)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,662) (7,895) (2,052) (908)

ChromaDex Inc. CDXC Recent News

Sept 25, 2013 Clinical Study Demonstrates ChromaDex's Caffeine Alternative, PURENERGY(TM), Delivers 30% More Caffeine, Stays in the Blood Stream Longer and is Absorbed More Slowly than Ordinary Caffeine
Aug 16, 2013 OTC Daily Alert Stock Watch - ChromaDex Inc. (OTCQB: CDXC)
Aug 13, 2013 ChromaDex® Reports Results for the Second Quarter 2013
Aug 5, 2013 ChromaDex® Acquires New Exclusive Worldwide Patent Rights for pTeroPure® Pterostilbene Relating to Skin Care
Jul 29, 2013 ChromaDex® Enters into Agreement with Beckman Research Institute of City of Hope to Supply pTeroPure(TM) Pterostilbene for Cancer Research
Jul 10, 2013 Spherix Announces Results of Studies to Explore Sports and Nutrition/Nutraceutical Markets for D-tagatose
Jul 8, 2013 ChromaDex® Announces Deal For Its Recently Launched Niagen(TM) Nicotinamide Riboside With Thorne Research


CDXC ChromaDex Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CDXC&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CDXC/quote
Stock Chart http://www.otcmarkets.com/stock/CDXC/chart
Company Info http://www.otcmarkets.com/stock/CDXC/company-info
Recent News http://www.otcmarkets.com/stock/CDXC/news
Financials http://www.otcmarkets.com/stock/CDXC/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CDXC/filings
Short Sales http://www.otcmarkets.com/stock/CDXC/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CDXC/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CDXC/research
Summary http://finance.yahoo.com/q?s=CDXC
Historical Prices http://finance.yahoo.com/q/hp?s=CDXC+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CDXC
Basic Chart http://finance.yahoo.com/q/bc?s=CDXC+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CDXC+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CDXC+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CDXC+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CDXC+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CDXC+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CDXC+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CDXC+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CDXC+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CDXC+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CDXC
Balance Sheet http://finance.yahoo.com/q/bs?s=CDXC
Cash Flow http://finance.yahoo.com/q/cf?s=CDXC+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CDXC
Market Watch http://www.marketwatch.com/investing/stock/CDXC
Bloomberg http://www.bloomberg.com/quote/CDXC:US
Morningstar http://quotes.morningstar.com/stock/s?t=CDXC
Bussinessweek http://investing.businessweek.com/research/st...icker=CDXC
Barchart http://www.barchart.com/quotes/stocks/CDXC
OTC Short Report http://otcshortreport.com/index.php?index=CDXC
Investopedia http://www.investopedia.com/markets/stocks/CDXC/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 956

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 251

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 295

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 307

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore Consciousness at the CONTACT Modalities XPO Gathering

Updated Category News Views 271

CONTACT Modalities XPO: A Unique Gathering for Consciousness Exploration Prepare to embark on a transformative journey of self-discovery and exploration at the CONTACT Modalities XPO. This gathering promises to bring together passionate individuals eager to delve into consciousness studies through engaging sessions and workshops. The event will be held at the stunning...

Continue Reading
Green Thumb Industries Set to Unveil Q3 2025 Financial Overview

Updated Category News Views 266

Green Thumb Industries to Report Third Quarter Financial Results Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), a standout in the cannabis consumer packaged goods sector, is poised to unveil its financial performance for the third quarter of 2025. The eagerly anticipated announcement will occur after market hours on November 5, 2025. Known for its growth and...

Continue Reading
Boussard & Gavaudan Holding: Estimated NAV Update

Updated Category News Views 129

About Boussard & Gavaudan Holding Limited Boussard & Gavaudan Holding Limited aims to keep shareholders informed—plain and simple. The company provides timely updates on its estimated net asset values (NAVs) and on the performance of its Euro and Sterling share classes, so you can track what matters without guesswork. How the Estimated NAV Is Determined Each month, the...

Continue Reading
Booming Yacht Rental Market Set to Surpass $13 Billion Milestone

Updated Category News Views 93

The yacht rental market hit a turning point, projected to exceed $13.1 billion in value—back when those forecasts came out, traders were buzzing about it. The allure of luxury travel had folks flocking to yacht rentals like moths to a flame. Market Drivers: Luxury Demand or Overhyped? High-net-worth individuals fueled the demand for yacht rentals, as they sought...

Continue Reading
Hellenic Telecom Completes Share Repurchase, Strengthening Value

Updated Category News Views 156

Hellenic Telecom's Successful Share Buyback Program Hellenic Telecommunications Organization S.A. (ATH:HTO), widely recognized as OTE, has recently finished a significant week of share repurchasing. In a strategic move, the company acquired a total of 414,128 shares, investing approximately €6.16 million at an average price of €14.87 per share. Understanding the Share...

Continue Reading